Enhanced Efficacy and Confirmed Safety of a Two-Year Epicutaneous Immunotherapy (EPIT) Treatment of Peanut Allergy with Viaskin (R) Peanut: The Continuation of the Vipes Phase IIb Randomized Controlled Trial (RCT) Sampson, H. A., Agbotounou, W., Thebault, C., Ruban, C., Martin, L., Sussman, G. L., Brown-Whitehorn, T. F., Yang, W. H., Nadeau, K. C., Cheema, A., Leonard, S. A., Sauvage, C., Assa'ad, A. H., de Blay, F., Bird, J., Tilles, S. A., Boralevi, F., Bourrier, T., Benhamou, P., Dupont, C. MOSBY-ELSEVIER. 2016: AB408

View details for DOI 10.1016/j.jaci.2015.12.1264

View details for Web of Science ID 000375005405040